Serum amyloid A: A potential biomarker of lung disorders.

Acute-phase protein Lung diseases Prognosis Serum amyloid A Serum biomarkers

Journal

Respiratory investigation
ISSN: 2212-5353
Titre abrégé: Respir Investig
Pays: Netherlands
ID NLM: 101581124

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 01 07 2019
revised: 29 08 2019
accepted: 20 09 2019
pubmed: 12 11 2019
medline: 5 8 2020
entrez: 12 11 2019
Statut: ppublish

Résumé

Serum amyloid A is an acute-phase protein with multiple immunological functions. Serum amyloid A is involved in lipid metabolism, inflammatory reactions, granuloma formation, and cancerogenesis. Additionally, serum amyloid A is involved in the pathogenesis of different autoimmune lung diseases. The levels of serum amyloid A has been evaluated in biological fluids of patients with different lung diseases, including autoimmune disorders, chronic obstructive pulmonary diseases, obstructive sleep apnea syndrome, sarcoidosis, asthma, lung cancer, and other lung disorders, such as idiopathic pulmonary fibrosis, tuberculosis, radiation pneumonitis, and cystic fibrosis. This review focuses on the cellular and molecular interactions of serum amyloid A in different lung diseases and suggests this acute-phase protein as a prognostic marker.

Identifiants

pubmed: 31708467
pii: S2212-5345(19)30165-0
doi: 10.1016/j.resinv.2019.09.005
pii:
doi:

Substances chimiques

Amyloid 0
Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-27

Informations de copyright

Copyright © 2019 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Auteurs

Lucia Vietri (L)

Department of Medical and Surgical Sciences and Neurosciences, Respiratory Disease and Lung Transplant Unit, Siena University, Siena, Italy. Electronic address: lucia.vietri89@gmail.com.

Annalisa Fui (A)

Department of Medical and Surgical Sciences and Neurosciences, Respiratory Disease and Lung Transplant Unit, Siena University, Siena, Italy. Electronic address: annalisafui@gmail.com.

Laura Bergantini (L)

Department of Medical and Surgical Sciences and Neurosciences, Respiratory Disease and Lung Transplant Unit, Siena University, Siena, Italy. Electronic address: Laurabergantini@gmail.com.

Miriana d'Alessandro (M)

Department of Medical and Surgical Sciences and Neurosciences, Respiratory Disease and Lung Transplant Unit, Siena University, Siena, Italy. Electronic address: miriana.dalessand@student.unisi.it.

Paolo Cameli (P)

Department of Medical and Surgical Sciences and Neurosciences, Respiratory Disease and Lung Transplant Unit, Siena University, Siena, Italy. Electronic address: Paolocameli88@gmail.com.

Piersante Sestini (P)

Department of Medical and Surgical Sciences and Neurosciences, Respiratory Disease and Lung Transplant Unit, Siena University, Siena, Italy. Electronic address: Sestini@unisi.it.

Paola Rottoli (P)

Department of Medical and Surgical Sciences and Neurosciences, Respiratory Disease and Lung Transplant Unit, Siena University, Siena, Italy. Electronic address: rottoli@unisi.it.

Elena Bargagli (E)

Department of Medical and Surgical Sciences and Neurosciences, Respiratory Disease and Lung Transplant Unit, Siena University, Siena, Italy. Electronic address: bargagli2@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH